Landfar(SZ:000504) Zheng Quan Zhi Xing·2025-07-06 08:17Group 1 - The company, Nanhua Biomedical Co., Ltd., has announced the lifting of restrictions on the issuance of 18,449,197 shares, which accounts for 5.59% of the total share capital [1][2] - The shares were issued to a specific entity, Hunan Caixin Industrial Fund Management Co., Ltd., at a price of 14.96 yuan per share, with a total capital increase of approximately 276 million yuan [1][2] - Following the issuance, the total share capital of the company increased from 311,573,901 shares to 330,023,098 shares, with restricted shares now totaling 19,354,397 shares, representing 5.86% of the total share capital [2][3] Group 2 - The lifting of the share restrictions is in compliance with the commitments made by the shareholder, and there have been no violations of these commitments [2][4] - The company has received approval from the China Securities Regulatory Commission for the issuance of shares, and the lifting of restrictions aligns with relevant laws and regulations [3][4] - The underwriter, Western Securities Co., Ltd., has confirmed that the lifting of restrictions and the subsequent listing of shares comply with all regulatory requirements [4]